Literature DB >> 3101725

The effects of moderate sustained exercise on the pharmacokinetics of nitroglycerine.

S Weber, D de Lauture, E Rey, T Darragon, J P Severins, A Ditisheim, G Olive, M Degeorges.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3101725      PMCID： PMC1386149          DOI： 10.1111/j.1365-2125.1987.tb03018.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  5 in total

1.  Influence of posture on plasma nitroglycerin.

Authors:  S H Curry; H R Kwon
Journal:  Br J Clin Pharmacol       Date:  1985-03       Impact factor: 4.335

2.  Studies of the bioavailability of nitroglycerin from a transdermal therapeutic system (Nitroderm TTS).

Authors:  P R Imhof; T Vuillemin; A Gérardin; A Racine; P Müller; F Follath
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

Review 3.  Effect of acute and chronic exercise on hepatic drug metabolism.

Authors:  M Døssing
Journal:  Clin Pharmacokinet       Date:  1985 Sep-Oct       Impact factor: 6.447

4.  Pharmacological interaction between nitroglycerin and aspirin after acute and chronic aspirin treatment of healthy subjects.

Authors:  E Rey; H D El-Assaf; M O Richard; S Weber; A Bourdon; G Picard; G Olive
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

5.  Steady state pharmacokinetic haemodynamic studies of intravenous nitroglycerin in congestive cardiac failure.

Authors:  P W Armstrong; D G Watts; J A Moffat
Journal:  Br J Clin Pharmacol       Date:  1983-10       Impact factor: 4.335
  5 in total
  12 in total

1.  Heating and cooling of the nitroglycerin patch application area modify the plasma level of nitroglycerin.

Authors:  T O Klemsdal; K Gjesdal; J E Bredesen
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

2.  The effect of transdermal nitroglycerin on exercise tolerance in relation to patch application time--a meta-analysis.

Authors:  T O Klemsdal; K Gjesdal
Journal:  Cardiovasc Drugs Ther       Date:  1992-12       Impact factor: 3.727

3.  Transdermal patch drug delivery interactions with exercise.

Authors:  Thomas L Lenz; Nicole Gillespie
Journal:  Sports Med       Date:  2011-03-01       Impact factor: 11.136

Review 4.  Influence of exercise on the pharmacokinetics of drugs.

Authors:  M A van Baak
Journal:  Clin Pharmacokinet       Date:  1990-07       Impact factor: 6.447

5.  Influence of exercise on nitroglycerin plasma concentrations after transdermal application.

Authors:  R A Lefebvre; M G Bogaert; O Teirlynck; A Sioufi; J P Dubois
Journal:  Br J Clin Pharmacol       Date:  1990-08       Impact factor: 4.335

6.  Influence of exercise on plasma concentrations of isosorbide dinitrate.

Authors:  M G Bogaert; R A Lefebvre; M T Rosseel; J Bouckaert
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

Review 7.  Transdermal nitroglycerin (glyceryl trinitrate). A review of its pharmacology and therapeutic use.

Authors:  P A Todd; K L Goa; H D Langtry
Journal:  Drugs       Date:  1990-12       Impact factor: 9.546

Review 8.  Clinical pharmacokinetics of nitrates.

Authors:  M G Bogaert
Journal:  Cardiovasc Drugs Ther       Date:  1994-10       Impact factor: 3.727

9.  Transdermal nitrate therapy: bioavailability during exercise increases transiently after the daily change of patch.

Authors:  K Gjesdal; T O Klemsdal; E O Rykke; J E Bredesen
Journal:  Br J Clin Pharmacol       Date:  1991-05       Impact factor: 4.335

Review 10.  Relationship of pharmacokinetic and pharmacodynamic properties of the organic nitrates.

Authors:  U Thadani; T Whitsett
Journal:  Clin Pharmacokinet       Date:  1988-07       Impact factor: 6.447
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.